Paragon Associates & Paragon Associates Ii Joint Venture Iridex Corp Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $58.7 Million
- Q2 2025
A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Iridex Corp stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 1,000,000 shares of IRIX stock, worth $1.3 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$1.3 Million
Previous $990,000
11.11%
% of portfolio
1.5%
Previous 2.49%
Shares
10 transactions
Others Institutions Holding IRIX
# of Institutions
22Shares Held
2.69MCall Options Held
36.1KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA586KShares$761,5560.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$492,3880.0% of portfolio
-
Amh Equity LTD190KShares$247,0000.23% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$171,2970.0% of portfolio
-
Apexium Financial, LP65.7KShares$85,4030.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $20.8M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...